Abstract: A tailgate pad. The tailgate pad includes a front side. The tailgate pad also includes a back side. The tailgate pad further includes a fold out panel coupled with the front side, the fold out panel to wrap about at least a portion of a wheel of a vehicle.

Abstract: An adjustable tailgate pad. The adjustable tailgate pad includes a front side. The adjustable tailgate pad also includes a back side. The adjustable tailgate pad further includes an adjustable top side coupled to the front side and the back side. The adjustable top side has a width which is adjustable.

Abstract: Described systems and techniques provide fast, efficient, and cost-effective techniques for detecting anomalous behaviors of monitored objects. Multiple hashing algorithms, each providing multiple hash bins, may be used to generate a unique hash signature for each of the monitored objects. Metric values characterizing the behavior of the monitored objects may be aggregated within individual ones of the multiple hash bins of each of the multiple hashing algorithms. Then, one or more machine learning models may be trained using the unique hash signatures and their included, aggregated metric values. During subsequent scoring using the trained machine learning model(s), each of the aggregated metric values of each of the hash bins may be scored, and a single or small subset of anomalous objects may be identified.

Abstract: A tailgate pad. The tailgate pad includes a front side. The tailgate pad also includes a back side. The tailgate pad further includes a fold out panel coupled with the front side, the fold out panel to wrap about at least a portion of a wheel of a vehicle.

Abstract: A tailgate pad. The tailgate pad includes a front side. The tailgate pad also includes a back side. The tailgate pad further includes a fold out panel coupled with the front side, the fold out panel to wrap about at least a portion of a wheel of a vehicle.

Abstract: The present application describes a two-step drug delivery formulation comprising a high affinity interaction between a drug conjugate and a compound, followed by introduction of a second compound with higher affinity to the drug conjugate to facilitate drug release. Delivery methods and specific interactions are also described.

Abstract: An adjustable tailgate pad. The adjustable tailgate pad includes a front side. The adjustable tailgate pad also includes a back side. The adjustable tailgate pad further includes an adjustable top side coupled to the front side and the back side. The adjustable top side has a width which is adjustable.

Abstract: An adjustable tailgate pad. The adjustable tailgate pad includes a front side. The adjustable tailgate pad also includes a back side. The adjustable tailgate pad further includes an adjustable top side coupled to the front side and the back side. The adjustable top side has a width which is adjustable.

Abstract: A tailgate pad. The tailgate pad includes a front side. The tailgate pad also includes a back side. The tailgate pad further includes a fold out panel coupled with the front side, the fold out panel to wrap about at least a portion of a wheel of a vehicle.

Abstract: An adjustable tailgate pad. The adjustable tailgate pad includes a front side. The adjustable tailgate pad also includes a back side. The adjustable tailgate pad further includes an adjustable top side coupled to the front side and the back side. The adjustable top side has a width which is adjustable.

Abstract: The present application describes a two-step drug delivery formulation comprising a high affinity interaction between a drug conjugate and a compound, followed by introduction of a second compound with higher affinity to the drug conjugate to facilitate drug release. Delivery methods and specific interactions are also described.

Abstract: The present application describes a two-step drug delivery formulation comprising a high affinity interaction between a drug conjugate and a compound, followed by introduction of a second compound with higher affinity to the drug conjugate to facilitate drug release. Delivery methods and specific interactions are also described.

Abstract: The present application describes a two-step drug delivery formulation comprising a high affinity interaction between a drug conjugate and a compound, followed by introduction of a second compound with higher affinity to the drug conjugate to facilitate drug release. Delivery methods and specific interactions are also described.